Melanoma Trial, Recruiting NCT07421739 Sponsor: Aura Biosciences Condition: Melanoma
Printed from Voxsanity (voxsanity.com.au) — NCT07421739 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.
Back to Melanoma

Melanoma Trial, Recruiting

NCT07421739
Recruiting Not Applicable 🇦🇺 Australian site

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have already enrolled in a separate Aura-sponsored clinical trial called AU-011-301.
  • People who have access to a connected device, such as a smartphone, laptop, or tablet.

Who may not be able to join:

  • There are no listed exclusion criteria for this trial.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Study Director, Aura Biosciences

Phone: 617-500-8864

Australian sites

Eye Research Australia, East Melbourne, Victoria

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Aura Biosciences
Registry
ClinicalTrials.gov
Start date
12 November 2025
Est. completion
15 August 2028

Where this trial is recruiting

🇦🇺 Australia

1 site(s) in Australia. Confirm current status and contact details directly with the trial site.

Primary endpoints

Change from baseline in EORTC QLQ-C30 scores at month 15 and 24.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Other trials for Melanoma

  • NCT02402244 Children's Oncology Group · Not Applicable · Recruiting · 🇦🇺 Australian site
  • NCT02821013 Canadian Cancer Trials Group · Phase 3 · Recruiting · 🇦🇺 Australian site
  • NCT03340129 Melanoma Institute Australia · Phase 2 · Recruiting · 🇦🇺 Australian site
  • NCT03860883 Melanoma and Skin Cancer Trials Limited · Not Applicable · Recruiting · 🇦🇺 Australian site
  • NCT03947385 IDEAYA Biosciences · Phase 2 · Recruiting · 🇦🇺 Australian site

Browse all trials for Melanoma →

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov